Related Experiment Video
Updated: Jul 15, 2026

07:29
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date
1College of Optometry, Nova Southeastern University, Ft. Lauderdale, FL, USA.
Summary
The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study tracked 1209 patients for 8 years, revealing vision decline and corneal changes. Factors like age and contact lens wear predict disease progression in keratoconus patients.
Area of Science:
- Ophthalmology
- Corneal Diseases
- Vision Science
Background:
- Keratoconus is a progressive corneal disease affecting vision.
- Longitudinal data on keratoconus progression and its impact on quality of life are crucial for patient management.
Purpose of the Study:
- To describe baseline and longitudinal findings of the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
- To characterize changes in vision, corneal curvature, corneal status, and vision-specific quality of life over 8 years.
Main Methods:
- An 8-year, multi-center, natural history study involving 1209 patients with keratoconus.
- Annual examinations assessing visual acuity, corneal topography, corneal health, and quality of life using the National Eye Institute Visual Function Questionnaire.
Main Results:
- A mean decrease in best-corrected visual acuity (high and low contrast) was observed over 7 years.
- Corneal curvature increased by an average of 1.60D over 8 years, with 24% showing increases of 3.00D or more.
- The 8-year incidence of corneal scarring was 20%, with younger age, corneal staining, steeper baseline curvature, contact lens wear, and poorer low-contrast acuity as predictors.
- Keratoconus significantly impacted vision-specific quality of life, disproportionate to its prevalence and severity.
Conclusions:
- Clinicians can predict keratoconus progression by identifying predictive factors in individual patients.
- Understanding these factors aids in managing the disease course and patient outcomes.